GlassScriptPhysician profile
Linda Lapos
NPI 1841249406
$991.97
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $63.19 · 2021: $199 · 2022: $212 · 2023: $245 · 2024: $86.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $331.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $322.48 | 2021-2024 | Interstim |
| Ferring Pharmaceuticals INC. | $175.30 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $155.15 | 2022-2023 | Gattex |
| Integra Lifesciences Corporation | $87.64 | 2021-2022 | |
| Shire North American Group INC | $65.30 | 2019 | |
| Braintree Laboratories, INC. | $48.90 | 2019-2023 | Sutab |
| Innovation Technologies INC | $33.34 | 2023-2024 | Irrisept |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.85 | 2021-2022 | |
| Axonics, INC. | $29.96 | 2020-2022 | |
| Trevena, INC. | $24.45 | 2022 | |
| Covidien LP | $11.74 | 2020 | |
| Thd America, INC. | $6.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda Lapos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.